Karyopharm - oncology

Discussion in 'Biotech Startups' started by anonymous, Jun 30, 2018 at 9:56 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    A lot of double dipping from now until Oct 1
     

  2. anonymous

    anonymous Guest


    I know of 5 alone who are giving their notice on the 2nd.
     
  3. anonymous

    anonymous Guest

    Anddddddddddddddddddddddddddd. 2 Marketing folks gone......... KPTI Derailed and off the tracks. Choo Choo!!!!!
     
  4. anonymous

    anonymous Guest

    So another RBD (great guy that saw through all the BS) off to greener pastures. Who is next? 2 more by first week in November? Over/under?
     
  5. anonymous

    anonymous Guest

    Great guy who many will follow. Too little, too late from PM, JD, and MK.
     
  6. anonymous

    anonymous Guest

    Definitely a big loss...once managers start leaving you know it’s bad. Neither took a promotion/higher level position. Lateral moves for both save for the financials...however one rarely knows the complete comp package until it is presented so they were both looking...if this doesn’t speak volumes you are not listening.
     
  7. anonymous

    anonymous Guest

    This board needs to out leadership. This stock has stagnated long enough. The creators of the drug can rarely run the company well. Geet them out, sell the company, and treat the shareholders with some respect.
     
  8. anonymous

    anonymous Guest


    Let’s see...a CEO who has no commercial experience, who’s wife is now involving herself in commercial also with no experience, showing a clear signal they have no faith in JD or PM. Add to that MK has an unrealistic view of Seli, so he’ll be the last recognize it’s a dog. At this point we are slightly above Clovis on the crazy scale losing good reps and managers left and right while the stock declines and revenue is staggered. But what the heck...let’s just throw on a dozen more zooms and fill out some more spread sheets. That ought to fix it...
     
  9. anonymous

    anonymous Guest

    To those who left, be thankful that you did. It has only gotten worse...a lot worse. Should have left with my RBD...bad decision to stick it out.
     
  10. anonymous

    anonymous Guest


    Another mass exodus coming. This place is a joke...with a very mediocre drug at best.
     
  11. anonymous

    anonymous Guest

    Perry is in over his head
     
  12. anonymous

    anonymous Guest

    No kidding...anyone surprised about that? He is weak and lacks any sort of substance and just regurgitates dumb things he’s heard over the years...and enough of him trying so hard to be funny. He is so corny/cheesy and no one is laughing...except at him. He is the joke.
     
  13. anonymous

    anonymous Guest

    Everyone wants to work for a company where the executives call you on the phone to check in just to see how many calls you made, right?
     
  14. anonymous

    anonymous Guest


    That’s what I signed up for...their micromanagement shows us that they care about our success. If only we had more spread sheets and account plans to complete...that would fix it all.
     
  15. anonymous

    anonymous Guest

    Good luck to you all. It’ll be interesting.
     
  16. anonymous

    anonymous Guest

    Share price???
     
  17. anonymous

    anonymous Guest

    Hopefully the new ceo will put some lipstick on this pig and sell so we can all move on.
     
  18. anonymous

    anonymous Guest

    The market reaction so far isn’t exactly a ringing vote of confidence on the new guy.
     
  19. anonymous

    anonymous Guest

    RP is an odd choice for sure. He was the “CEO” of Ipsen NA which is basically a zone VP and not the real ceo. Inflated title for sure. It would have been great to bring in a CEO who has actually executed deals that we are in search/need of. Lastly I was on the Kyprolis team at Onyx/Amgen and RP had little to no real hands on responsibility for Kyprolis. All the heavy lifting was done well before the acquisition and RP wasn’t around all that long with Kyprolis under his watch and lastly it didn’t do well when it was.
     
  20. anonymous

    anonymous Guest


    Now I know who you are!